JS212
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for JS212, covering 2025-06-19 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma [Phase 2]